135 related articles for article (PubMed ID: 35503980)
1. Population Pharmacokinetics of Intranasal Dexmedetomidine in Infants and Young Children.
Li BL; Guan YP; Yuen VM; Wei W; Huang M; Zhang MZ; Li AW; Standing JF; Zhong GP; Song XR
Anesthesiology; 2022 Aug; 137(2):163-175. PubMed ID: 35503980
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of dexmedetomidine in infants after open heart surgery.
Su F; Nicolson SC; Gastonguay MR; Barrett JS; Adamson PC; Kang DS; Godinez RI; Zuppa AF
Anesth Analg; 2010 May; 110(5):1383-92. PubMed ID: 20418300
[TBL] [Abstract][Full Text] [Related]
3. Dose Escalation Pharmacokinetic Study of Intranasal Atomized Dexmedetomidine in Pediatric Patients With Congenital Heart Disease.
Grogan K; Thibault C; Moorthy G; Prodell J; Nicolson SC; Zuppa A
Anesth Analg; 2023 Jan; 136(1):152-162. PubMed ID: 35446797
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children.
Wang CY; Ihmsen H; Hu ZY; Chen J; Ye XF; Chen F; Lu Y; Schüttler J; Lian QQ; Liu HC
Front Pharmacol; 2019; 10():756. PubMed ID: 31333469
[No Abstract] [Full Text] [Related]
6. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.
Liu HC; Lian QQ; Wu FF; Wang CY; Sun W; Zheng LD; Schüttler J; Ihmsen H
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):201-211. PubMed ID: 27037817
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens.
James NT; Breeyear JH; Caprioli R; Edwards T; Hachey B; Kannankeril PJ; Keaton JM; Marshall MD; Van Driest SL; Choi L
Br J Clin Pharmacol; 2022 Jun; 88(6):2885-2898. PubMed ID: 34957589
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine disposition in children: a population analysis.
Potts AL; Warman GR; Anderson BJ
Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis.
Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S
Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
Zimmerman KO; Wu H; Laughon M; Greenberg RG; Walczak R; Schulman SR; Smith PB; Hornik CP; Cohen-Wolkowiez M; Watt KM
Anesth Analg; 2019 Dec; 129(6):1519-1528. PubMed ID: 31743171
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients.
Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A
J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578
[TBL] [Abstract][Full Text] [Related]
14. Dosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study.
Miller JW; Divanovic AA; Hossain MM; Mahmoud MA; Loepke AW
Can J Anaesth; 2016 Jul; 63(7):834-41. PubMed ID: 26883963
[TBL] [Abstract][Full Text] [Related]
15. Median Effective Dose of Intranasal Dexmedetomidine for Rescue Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging.
Zhang W; Fan Y; Zhao T; Chen J; Zhang G; Song X
Anesthesiology; 2016 Dec; 125(6):1130-1135. PubMed ID: 27627818
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients.
Uusalo P; Guillaume S; Siren S; Manner T; Vilo S; Scheinin M; Saari TI
Anesth Analg; 2020 Apr; 130(4):949-957. PubMed ID: 31206433
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Clearance Decreases with Increasing Drug Exposure: Implications for Current Dosing Regimens and Target-controlled Infusion Models Assuming Linear Pharmacokinetics.
Alvarez-Jimenez R; Weerink MAS; Hannivoort LN; Su H; Struys MMRF; Loer SA; Colin PJ
Anesthesiology; 2022 Feb; 136(2):279-292. PubMed ID: 34851425
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass.
Kim EH; Choi BM; Kang P; Lee JH; Kim HS; Jang YE; Ji SH; Noh GJ; Cho JY; Kim JT
Paediatr Anaesth; 2023 Apr; 33(4):303-311. PubMed ID: 36594749
[TBL] [Abstract][Full Text] [Related]
19. A Population Pharmacokinetic Model of Intravenous Dexmedetomidine for Mechanically Ventilated Children after Neurosurgery.
Song IK; Yi S; Lim HS; Lee JH; Kim EH; Cho JY; Kim MC; Kim JT; Kim HS
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581476
[TBL] [Abstract][Full Text] [Related]
20. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
Fabre MA; Fuseau E; Ficheux H
J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
